Cell & Gene Therapies

PACT Pharma raises $75M to expand cell therapy manufacturing

23-Jan-2020 By Nick Taylor

PACT Pharma reels in Series C financing round to support expansion of cell therapy manufacturing capacity.

Boom in number of UK cell and gene therapy clinical trials

22-Jan-2020 By Ben Hargreaves

Year-on-year, the number of trials for advanced therapeutics has doubled, meaning that the UK now represents 12% of all global clinical trials in the area.

Sarepta tips Roche pact to spur manufacturing capacity expansion

21-Jan-2020 By Nick Taylor

Sarepta expects its $1bn gene therapy pact with Roche to necessitate the addition of manufacturing capacity.

Nationwide Children’s Hospital creates for-profit gene therapy CMO

20-Jan-2020 By Nick Taylor

Nationwide Children’s Hospital creates Andelyn Biosciences to provide gene therapy manufacturing services.

Commercial manufacture of Bluebird’s gene therapy begins, launched in Germany

16-Jan-2020 By Ben Hargreaves

Apceth announces that it has started the commercial manufacture of Zyntelgo, after health insurance companies in Germany agree to pricing structure.

Astellas continues to make deals, partnering with Adaptimmune

15-Jan-2020 By Ben Hargreaves

The newly established deal includes the co-development of up to three T-cell therapies, by utilizing the latter’s stem-cell derived allogeneic T-cell platform.

Yposkesi doubles manufacturing footprint to meet AAVs growing demand

14-Jan-2020 By Vassia Barba

Yposkesi CDMO announces expansion to cover growing demand, strikes a deal on viral vectors production for a gene therapy development project.

Astellas acquires Xyphos and its CAR-T technology for $665m

09-Jan-2020 By Ben Hargreaves

Astellas continues its acquisition spree in the advanced therapeutics space through a deal for Xyphos and its next-generation take on CAR-T therapies.

Charles River closes $380m HemaCare cell therapy takeover

07-Jan-2020 By Nick Taylor

Charles River Laboratories closes $380m takeover of cell therapy specialist HemaCare to expand in fast-growing sector.

Filling UK bioprocessing roles a ‘substantial concern’

06-Jan-2020 By Ben Hargreaves

With the number of roles in manufacturing projected to rise by 196% over the next five years, industry fears a lack of expertise to fill vacuum, according to survey.

Bristol-Myers touts CAR-T manufacturing optimization ahead of FDA filing

19-Dec-2019 By Nick Taylor

Bristol-Myers Squibb presents data showing impact of optimization effort on CAR-T production.

Novartis sets 2020 target for commercial readiness of cell therapy CMO

10-Dec-2019 By Nick Taylor

Novartis aims to have its Japanese cell therapy CMO commercially ready in the second half of 2020.

CSafe launches temperature-controlled packaging for cell therapies

10-Dec-2019 By Vassia Barba

CSafe expands its cold chain offering with a series of logistics services suitable for temperature-controlled shipping of biologics.

‘High performance’ membrane for in situ cell filtration

10-Dec-2019 By Vassia Barba

Securecell introduces Sephara, an in situ filtration membrane with precise pore size for continuous production of antibodies and exosomes.

Biosana and A*STAR in continuous bioprocessing laboratory project

10-Dec-2019 By Vassia Barba

Biosana to work collaboratively with the Bioprocessing Technology Institute, aiming to design a highly flexible and cost-effective continuous manufacturing solution.